SHPH - Shuttle Pharmaceuticals Holdings, Inc.
0.6701
-0.025 -3.716%
Share volume: 29,551
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.20%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.04
-0.06%
View ratios
Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2024-09-04 | 2024-09-04 | 2024-11-13 | |
Cash flow financing | -40.000 K | -461.667 K | -196.790 K | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | |
Cash flow | -1.178 M | -703.034 K | -538.938 K | |
Net income | -1.731 M | -2.031 M | -3.784 M | |
Depreciation | 1.912 K | 962.000 | 793.000 | |
Changes in inventories | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | 101.295 K | 1.158 M | 1.656 M | |
Net Borrowings | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | |
Cash Change | -1.178 M | -703.034 K | -538.938 K |